XML 14 R5.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Cash flow from operating activities    
Net loss $ (3,968) $ (3,593)
Adjustments to reconcile net loss to net cash used in operating activities    
Stock-based compensation 338 263
Amortization of technology license 0 80
Amortization of right of use assets 56 0
Depreciation 99 132
(Increase) decrease in operating assets    
Prepaid drug product for testing (322) (215)
Other current assets (42) (251)
Increase (decrease) in operating liabilities    
Accounts payable and accrued expenses (328) 214
Lease liabilities (56) 0
Net cash used in operating activities (4,223) (3,370)
Cash flow from investing activities    
Purchases of furniture, fixtures & equipment 0 (17)
Net cash used in investing activities 0 (17)
Cash flow from financing activities    
Net proceeds from sale of common stock 19,411 0
Net proceeds from exercise of warrants 914 0
Net cash provided by financing activities 20,325 0
Net increase (decrease) in cash 16,102 (3,387)
Cash, beginning of period 1,004 5,965
Cash, end of period $ 17,106 $ 2,578